William Saunderson-Meyer on Ivermectin as an alternative for Covid

Loading player...
William Saunderson-Meyer outlines the contradictories in research around Ivermectin all around the world. The drug has become one of most hotly debated topics over the last twelve months, given its apparent miracle-like effects at preventing Covid-19, despite full clinical trials having not been conducted. Learn more about your ad choices. Visit megaphone.fm/adchoices
1 Jul 2021 9AM English South Africa Investing · Business News

Other recent episodes

Members Only: FT Unhedged – Energy crisis deepens as supply shocks ripple globally

In this fully licensed episode of the Financial Times’ Unhedged podcast, Katie Martin and energy editor Malcolm Moore unpack the escalating global energy crisis triggered by disruption in the Strait of Hormuz. With millions of barrels of oil effectively trapped and supply chains under strain, the impact is already being…
7 Apr 12PM 19 min

Ivor Chipkin: GNU outlaws cadré deployment

President Cyril Ramaphosa's assent to the Public Service Amendment Bill has been hailed as the most significant reform since 1996. In this interview with Chris Steyn, Ivor Chipkin, the Director of New South Institute (NSI), says “we've got now in law a distinction between political office and administrative office…Our politicians,…
7 Apr 9AM 21 min

From Ceres to New York: Adriaan Wildschutt sets a blistering pace

Adriaan Wildschutt came so close to an Olympic medal in Paris, delivering the country’s strongest performance at the 2024 Games. With no track world championships on the calendar this year, Wildschutt shifted his focus to the roads and stormed to victory at the New York City Half Marathon in a…
2 Apr 9AM 14 min